92 related articles for article (PubMed ID: 15613102)
1. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy.
Fioredda F; Plebani A; Hanau G; Haupt R; Giacchino M; Barisone E; Balbo L; Castagnola E
Eur J Haematol; 2005 Jan; 74(1):20-3. PubMed ID: 15613102
[TBL] [Abstract][Full Text] [Related]
2. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
3. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
4. Revaccination of children after completion of standard chemotherapy for acute leukemia.
Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT
Clin Infect Dis; 2007 Mar; 44(5):635-42. PubMed ID: 17278052
[TBL] [Abstract][Full Text] [Related]
5. [The assessment of efficacy of hepatitis B prophylaxis in children with acute lymphoblastic leukemia].
Moryl-Bujakowska A; Czogała M; Czogała W; Balwierz W
Przegl Lek; 2004; 61 Suppl 2():85-8. PubMed ID: 15686054
[TBL] [Abstract][Full Text] [Related]
6. Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia.
Yetgin S; Tavil B; Aytac S; Kuskonmaz B; Kanra G
Leuk Res; 2007 Apr; 31(4):493-6. PubMed ID: 16930691
[TBL] [Abstract][Full Text] [Related]
7. Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules.
Lehrnbecher T; Schubert R; Allwinn R; Dogan K; Koehl U; Grüttner HP
Br J Haematol; 2011 Mar; 152(6):754-7. PubMed ID: 21250973
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
Brodtman DH; Rosenthal DW; Redner A; Lanzkowsky P; Bonagura VR
J Pediatr; 2005 May; 146(5):654-61. PubMed ID: 15870670
[TBL] [Abstract][Full Text] [Related]
9. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination strategies.
Ek T; Mellander L; Hahn-Zoric M; Abrahamsson J
Acta Paediatr; 2006 Jun; 95(6):701-6. PubMed ID: 16754551
[TBL] [Abstract][Full Text] [Related]
10. Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia.
Lehrnbecher T; Schubert R; Behl M; Koenig M; Rose MA; Koehl U; Meisel R; Laws HJ
Br J Haematol; 2009 Dec; 147(5):700-5. PubMed ID: 19764991
[TBL] [Abstract][Full Text] [Related]
11. Immunization status of internationally adopted children in Italy.
Viviano E; Cataldo F; Accomando S; Firenze A; Valenti RM; Romano N
Vaccine; 2006 May; 24(19):4138-43. PubMed ID: 16545505
[TBL] [Abstract][Full Text] [Related]
12. [Serological study carried out in Cambodia during a tetanus vaccination in adults].
Schlumberger M; Yvonnet B; Que HV; Chhem DB; Saliou P; Le Tu TC; Glaziou P
Bull Soc Pathol Exot; 2008 Feb; 101(1):36-42. PubMed ID: 18432006
[TBL] [Abstract][Full Text] [Related]
13. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Fioredda F; Giacchino M; Castagnola E
Cancer; 2005 Apr; 103(8):1758-9; author reply 1760. PubMed ID: 15717298
[No Abstract] [Full Text] [Related]
14. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Laws HJ; Calaminus G; Göbel U
Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299
[No Abstract] [Full Text] [Related]
15. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
[TBL] [Abstract][Full Text] [Related]
16. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
[TBL] [Abstract][Full Text] [Related]
17. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
18. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
19. Response to a vaccination schedule with 4 doses of 40 microg against hepatitis B virus in cirrhotic patients evaluated for liver transplantation.
Pascasio JM; Aoufi S; Gash A; Sousa JM; Perea R; Sayago M; Ferrer MT; Valencia R; Gómez-Bravo MA; Bernardos A; Márquez JL
Transplant Proc; 2008 Nov; 40(9):2943-5. PubMed ID: 19010154
[TBL] [Abstract][Full Text] [Related]
20. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]